Unveiling the Hidden Danger of Prosthesis Infolding

Since its inception in 2002, transcatheter aortic valve implantation (TAVI) has revolutionized the treatment landscape for symptomatic severe aortic stenosis. Over the years, this minimally invasive procedure has evolved into a cornerstone therapeutic option, catering to a broad spectrum of patients, including those deemed at low surgical risks1,2. The remarkable progress in TAVI technology, coupled with the growing expertise of operators, has propelled this procedure to achieve outcomes comparable with traditional surgical aortic valve replacement.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research